FDA planning for fewer food and drug inspections due to layoffs, officials say
Around 170 staff were cut from the FDA's Office of Inspections and Investigations this week as part of wider cuts at U.S.
Judge foils FDA plan to regulate lab-developed tests
The FDA finalized a rule to oversee lab-developed tests as if they were medical devices, prompting lawsuits. Opponents said ...
STAT1d
Makary’s first speech to FDA staff focuses on challenging norms, fighting chronic disease
In recording, Makary said little about specific plans for his agency or about the layoffs that have roiled his workforce.
BioSpace1d
Scott Steele Steps In as FDA’s Interim CBER Head After Marks’ Departure
Following the dramatic late-night resignation of Peter Marks last Friday, Steele, a senior advisor to the division, takes the ...
Fierce Pharma1d
For struggling cell and gene therapy field, Peter Marks' FDA exit adds even more uncertainty
The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...
Fierce Pharma1d
FDA taps insider Scott Steele to lead CBER on acting basis after Peter Marks departure
Amid a dramatic reshaping of the federal healthcare apparatus, the FDA has named an acting leader of its Center for Biologics Evaluation and Research. | Amid a dramatic reshaping of the federal ...
The Latest: Mass layoffs begin at the US Department of Health and Human Services
Employees across the U.S. Department of Health and Human Services began receiving notices of dismissal Tuesday, as part of a ...
STAT3d
Ouster of FDA’s Peter Marks alarms a biopharma industry that saw him as an ally
Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be ...